Professional Documents
Culture Documents
H
E
Most Disruptive
2021
VOL. 04
ISSUE-1
MedTech
Innovators for 2021
CONSTANT CHANGE
The importance of
continuous
innovation
in healthcare
TECH TIMELINE
The evolution of
MedTech devices
through the ages
ARTICLES
Constant Change Tech Timeline
The importance of continuous The evolution of MedTech
innovation in healthcare devices through the ages
CXO
Expert Opinion
How to Translate Data
into Revenue Growth
CONTENTS
Creavo
Transforming Future
of Cardiology with
Promethean Technology
COVER
STORY
sales@insightscare.com
April, 2021
Corporate Offices:
Insights Success Media Tech LLC Insights Success Media and Technology Pvt. Ltd.
555 Metro Place North, Suite 100, Office No. 22, Rainbow Plaza, Shivar Chowk,
Dublin, OH 43017, United States Pimple Saudagar, Pune, Maharashtra 411017
Phone - 302-319-9947 Phone - India: 7410033802, 74100058552
Email: info@insightscare.com Email: info@insightscare.com
For Subscription: www.insightscare.com For Subscription: www.insightscare.com
Copyright © 2021 Insights Success Media and Technology Pvt. Ltd., All rights reserved. The content and images used in this magazine should not be reproduced or
transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights success.
Reprint rights remain solely with Insights Success Media and Technology Pvt. Ltd. Insights Care is powered by Insights Success Media and Technology Pvt. Ltd.
1 T
H
E
MOST DISRUPTIVE
MedTech
INNOVATORS FOR 2021
Ariane Medical
Keith Spanswick Ariane Medical Systems specialises in equipment for
Systems Ltd
arianemedicalsystems.com Executive Chairman treating cancers using low energy photons (X Rays).
Cority Mark Wallace Cority is the global enterprise EHS software provider that
cority.com President and CEO empowers those who transform the way the world works.
Redefining Expertise
LipoCoat’s ceaseless journey towards
eminence is helmed by Jasper van
Weerd, the Founder and CEO.
Jasper holds an MSc degree in
Biomedical Engineering from the
University of Twente, the Netherlands.
‘
While a PhD student in
Supramolecular Chemistry at the same
Value-based healthcare—focusing on
university, he invented the unique
bioinspired LipoCoat® coatings.
Jasper was a visiting researcher at
PennState University (USA),
Politechnico Milano (Italy) and Utrecht
‘
treatment outcomes—and the use of
preventative innovations must take
University (the Netherlands). He is the up a more prominent position.
author of 11 peer reviewed
publications and the inventor of 3
‘
patents. In 2016, he founded LipoCoat
to make his invention available for the
general public.
Tackling Adversities
Talking about how the pandemic and
the entailing restrictions on business
operations impacted the company, the has been the transition to working from 2021 and in a few years’ time, it
team at LipoCoat® says, “The COVID- home when possible and an increased expects its first coated catheters to
19 pandemic forced us to change awareness of how new working enter the market. In addition, other use
various aspects of our lives.” routines (such as online meetings) can cases are actively explored in
be part of an efficient and modern LipoCoat’s discovery programs,
At LipoCoat®, employee safety and organization. including R&D tools, cell culture
well-being are of utmost importance. systems, cosmetic, and therapeutic
Being a biotech company R&D is its In Foresight applications.
key activity. At the beginning of the The COVID-19 pandemic has shown
pandemic, the company implemented the importance of scientific progress LipoCoat® has secured a €1.5 million
various employee safeguards to ensure regarding infection control. LipoCoat® investment round in the middle of the
lab work could be performed safely – is currently involved in development COVID-19 pandemic. To make the
in accordance with governmental programs with healthcare corporates leap to further growth, a funding round
regulations. that want to increase the safety of their of €5 million is planned for mid-2021.
medical devices. The company has With this investment round, LipoCoat®
“Social distancing, use of hand seen a very promising reduction in envisions building its revenue streams,
disinfectants, monitoring temperature, bacterial adhesion on contact lenses increasing its development and
rapid testing and other corona and catheters. production capacity, and expanding its
protocols have become our new international footprint by gaining
normal,” says the team. One of the LipoCoat® is aiming to launch access to USA and Asian markets, in
important developments at LipoCoat® LipoCoat-enabled contact lenses in the coming years.
SUBSCRIBE
TODAY
Never Miss An Issue
Stay in touch.
Subscribe to Insightscare Get Insightssuccess
Magazine in print, & digital on www.insightscare.com
www.insightscare.com
“
discipline has transformed the The Abilitech™
industry and what more could be
What makes your company a
expected in the near future?
Assist facilitates
preferred choice over your
competitors?
Assistive technology is a booming independent control
category for the med device industry.
The Abilitech Assist is the only body-
There have been many recent
of the arms by
worn assistive technology device that
empowers a movement of both the
breakthroughs by assistive devices, supporting and
including the Abilitech™ Assist. The
shoulder and the elbow. The hybrid assisting both the
technology uses springs, motors, and
software to optimize the support
needed for everyone without
overriding their existing function.
largest focus has been focused on
powering the legs or working on brain
interface technology, which is invasive,
expensive, and not accessible for
shoulder and elbow
for people with
“
Each patient can dynamically adjust
several years. Abilitech is focused on minimal strength.
the upper body and works with existing
their profile with the touch of a button
function, as opposed to fully robotic
to support them in lifting objects of
support, which would override patient
varying weights. The Abilitech Assist
strength and weaken the arms. The
innovation
healthcare
in
But how far we are in this 21st innovation cycle? Now, with
the technological advancement and its usage in healthcare,
O
ur freedom can be measured fundamental part of living in gained an edge over the established
by the number of things we society autonomously and freely, brands in this niche, Alfons says, “At
can walk away from.”Vernon engaging in daily activities. ABLE, we are trying to disrupt the
Howard, an American author, Ÿ Innovation: Cutting-edge exoskeleton market from the bottom up,
philosopher, and spiritual teacher said technology backed by research focusing on the design of exoskeletons
it rightly. But what about those people through the company's for specific pathologies, resulting in
who can't walk away from the collaboration with the UPC user-centered solutions withlightness,
toxicicity in their lives? And what Biomechanical Engineering Lab. adaptation to their motor capabilities,
about those people who can't walk Ÿ User-centered: Solutions at the continuum of care from the hospital to
without support? service of people. home, and cost-effectiveness.”
Ÿ Inclusiveness: Being different by
Enabling people to move on their own focusing on people and their issues. This approach, together with years of
is crucial to unleashing full human research at UPC and key partnerships,
potential. However, 0.1 billion people Accessibility at its core has led to the ABLE Exoskeleton: the
worldwide need a wheelchair to move Right after its inception, the company first lightweight, intuitive, and
around. Paralyzed individuals could took the first step towards its mission affordable robotic exoskeleton that
walk again by using a robotic by launching ABLE Exoskeleton. allows paraplegic individuals to stand
exoskeleton. However, due to their According to the company, it is the first up and walk autonomously.
high access price (120k€) and high lightweight, easy-to-use, and
weight (25 kg), exoskeletons are only affordable robotic exoskeleton that Alfons believes that the compact and
found in large hospitals. allows paraplegic individuals to stand lightweight design of the company's
up and walk again on their own. The exoskeleton, along with the significant
Alfons Carnicero, CEO and system incorporates the most advanced cost reduction, will drive a much faster
Co-founder was moved by these robotics and motion control penetration in the domestic market.
people's pain and made it a clear techniques, together with Machine
mission of enabling mobility to Learning algorithms to optimize the Avisionary
everyone by co-founding ABLE gait patterns. As a healthcare entrepreneur Alfons
Human Motion.“We create has participated in several acceleration
lightweight and affordable exoskeleton There are similar competitive devices programs including CRAASH
technology to empower every person in in the market that focus on targeting all Barcelona, Toyota Startup Accelerator,
a wheelchair, by providing better lower-limb mobility impairments with and CaixaImpulse. He also completed
mobility and greater independence,” a single device (one-size-fits-all various business and management
says Alfons. approach). This results in very courses at renowned universities such
expensive (from €60k to €150k), heavy as Cambridge Judge Business School,
He further explained the company's (from 14 to 25kg), and complex EADA, and ISDI.
core values that have helped ABLE devices that can only be afforded by
Human Motion to strongly march to large clinical institutions. He holds a Master's in Industrial and
achieving its mission. Biomedical Engineering from the
Ÿ Accessibility. Mobility is a Explaining how ABLE Human Motion UniversitatPolitècnica de Catalunya
“
An innovative step towards future
likelihood of accidents and falls. At ABLE, we are
New technologies have transformed However, not all it's good news here, trying to disrupt the
our society and our lives and have a
massive impact and the adaptation rate
as the pandemic has caused millions of exoskeleton market
deaths around the world and triggered
in the healthcare industry. The one of the largest economic crisis from the bottom up,
unprecedented speed at which the
COVID-19 vaccine has been
exposing the vulnerabilities of current focusing on the
healthcare systems and supply chains
design of
developed was possible due to the
years of previous research, worldwide
collaboration, faster manufacturing
methods, and enormous investments.
As for the current healthcare
and the worst inequalities between
continents and countries.“Now, while
we recover from this crisis,” says
Alfons, “As a society, we should
exoskeletons for
specific pathologies,
“
innovation, many of these are digitally
prioritize health and research to resulting in user-
promote well-being and prosperity in
enabled and driven by advancements in the years to come.” centered solutions.
robotics, artificial intelligence (AI),
new manufacturing methods, data The flexibility of work during the
analytics, and virtual reality. lockdown
“ABLE is one of the top health tech projects in Barcelona. A young but high-
performance team with enthusiasm to develop a new approach to
exoskeletons. They will be really good to deliver new technologies to solve a
serious health problem.”
– Pau Corbera, President at Advero Properties Socimi
By leveraging an integrated
payment platform that consolidates
data from multiple enterprise
systems, healthcare organizations
make it easier for their patients to
understand, manage and pay for
healthcare expenses. This data
creates the foundation for a
personalized and adaptive
experience that empowers patients
to confidently navigate the financial
responsibilities associated with their
care while improving revenue cycle
outcomes for health systems.
Many of the frustrations felt by patients are actually the With a payment platform that consolidates data across
result of point solutions that health systems rely upon for different systems, healthcare organizations can personalize
various revenue cycle processes such as scheduling, cost each patient's financial care in a scalable way. At the same
estimates, and eligibility. With so many siloed systems, time, this makes data actionable and enables revenue cycle
patients don't know which source of information to trust. team members to better assist patients navigate their
Patients get overwhelmed trying to figure out the nuances financial options.
of why they owe what they owe and make sense of their
financial obligations. Ultimately, they become disconnected Health systems can leverage data including a patient's
from the health system and patient loyalty is compromised. preferred communication, such as email or text, along with
other data, like bill balance amount and prior payment
Meanwhile, for busy RCM teams, responding to confused history to tailor outreach and payment options to each
patients who have questions about their financial patient. For example, health systems can encourage a
responsibilities can seem daunting, manual, and time- patient who has a large bill balance to sign up for a payment
consuming. Health systems employ hundreds of team plan with messaging on their bill and influence a patient
members to handle high volumes of manual tasks, such as with a smaller balance to pay in full with a prompt payment
answering patient phone calls, responding to email and discount.
patient portal messages, accepting, and posting payments
and more. Data that's consolidated and actionable allows health
systems to predict the best ways to drive patient
As a result, when patient visit volumes grow, so does the engagement, proactively meet patients' preferences and give
workload for these team members. There is an opportunity patients an easy way to manage their current and future
for technology to streamline these tasks, so team members expenses with tailored, self-service affordable payment
can focus on other efforts and enable the health system to options. This also empowers team members to offer better
care for more patients without significantly increasing support when patients need assistance most.
operational costs. Realizing this opportunity is key,
especially following the COVID-19 pandemic as many Collectively, by doing this for all patients in a health
health systems will have a backlog of elective procedures to system, health systems use what traditionally was
reschedule. transactional data to outline a better, more tailored financial
experience that delivers meaningful financial results for
Technologies, such as chatbots with natural language their organization.
processing and personalized self-service payment options
can empower health systems and their team members to
focus more on patient care and less on administrative tasks.
For instance, if a patient is anxious about the cost of their
care and has a question about their price estimate, the
patient can easily be guided by the chatbot to a personalized
view of the cost information they need including easy
instructions on enrolling in an affordable payment plan and
links to self-service scheduling. This all takes place with no
“
market surveillance processes. benefit of all. AI devices can automate Our
the basic and tedious tasks that
clinicians perform daily. This allows
deep-learning
Being an experienced leader in the
them to focus on complex solutions are
healthcare sector, share with us your
opinion on how the adaptation of
modern technology in the healthcare
discipline has transformed the
interpretation tasks and make more
data-driven and accurate follow-up
decisions.
tailored around
the needs and
input of clinical
“
industry and what more could be
Taking into consideration the
expected in the near future?
current pandemic, and its impact on
specialists.
The amount of medical data keeps global economies, how are you
growing, increasing the complexity of driving your organization to sustain
decision making for clinicians. AI is a operations and ensure safety of your
powerful technology because it can employees at the same time?
'learn' to identify patterns and nuances
For the past year, I witnessed the
MedTech
devices
through the ages
T he latest development of the COVID-19 vaccine within a
year of the viral spread also the involvement of humanoid
robots assisting healthcare professionals to lessen the
burden and provide accurate care during the pandemic has been
the new amazement for common people.
However, the MedTech field has always been evolving from the
first magnifying glass developed in 1250 to the new concept of
telehealth in the 21st century. Each of these evolutions has further
helped the healthcare field to provide safer, efficient, and widely
accessible healthcare services to patients. From the field rich of
healthcare experts, innovators, and genius minds we shed some
light on some of the amazing MedTech devices that have played
crucial roles in transforming lives.
“Current practice, quite rightly, treats all patients as if they “The wider MedTech industry has supported these teams in
are having a heart attack until proven otherwise, a process developing diagnostic technologies and vaccines in record
The team at Creavo believes that two key technological Towards a Successful Future
trends have and will continue to influence the delivery of Having a large study plan in 2021, Creavo aims to unlatch
global healthcare: across multiple hospitals in the UK and Europe followed by
a similar study in the United States. Making this a final
First, the advent of wearable and digital technologies has stage in acquiring their patient’s data and training their
led to a far more personal ownership and a more holistic machine learning algorithms and automating the diagnostic
view of personal health. This has allowed patients to take procedure that can be currently done manually by a highly
more personal ownership and contribute to better and trained individual.
earlier diagnosis via home monitoring or as in Creavo’s
case, the future ability to provide diagnostics much earlier The relatively short regulatory pathway once done, will
to patients. allow the Corsens® technology to roll out to hospitals
initially across Europe followed by the US and other global
The second is the wider management of patients with a total markets. Helping to enable accurate and timely diagnostics
focus and integration of pre-hospital, in-hospital, and post- at a patients’ bedside in a busy Emergency Room is one of
hospital care. Historically, the healthcare industry has the most challenging applications of the Corsens®
treated individual patient symptoms, via a cardiologist for a technology.
heart problem, an orthopedic surgeon, etc. rather than the
whole patient. Whilst individual clinical specialties are and Once released and proven in this environment there are
remain very important there is a movement to manage the several potential additional applications of this platform
whole patient, focused on disease prevention and earlier technology both in other areas of the hospital, but also in
discharge rather than in-hospital treatments. doctors’ offices and the wider community.